You searched for viral vector - Page 10 of 53

Best in Biotech 16 Nov 2022

Six biotech stocks trading below cash right now

…to Vaxzevria. Amongst other technologies, Vaccitech also harnesses the same adenoviral vector technology as Vaxzevria for the development of vaccines. The firm has candidates in the pipeline for the treatment…

November 16, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 11 Jan 2016

Transgene shares jump 50% in 2 days After Announcing Phase III Trial for Liver Cancer

…therapy which is delivered to cancer cells using a viral vector (to understand how these work, read our review on immuno-oncology). Pexa-Vec (pexastimogene devacirepvec) is the candidate in question, armed…

January 11, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 10 Feb 2023

Beyond Biotech podcast 33: Astellas Pharma, Innovation Agency Lithuania, 4basebio

…application-specific flexibility and benefits. 4basebio is also developing non-viral delivery technology to overcome some of the challenges associated with commonly used viral vector and LNP (lipid nanoparticle) solutions. Lithuania Despite…

February 10, 2023 - 2 minutesmins - By Jim Cornall

Best in Biotech 13 Mar 2025

Nine biotechs thriving in Seattle in 2025

…events in patients. Its VivoVec gene delivery platform uses lentiviral vectors to transport the CAR-T cells to specific tumor sites and attack them. This is combined with its Rapamycin-Activated Cytokine…

March 13, 2025 - 12 minutesmins - By Roohi Mariam Peter

Startup Scout 12 Oct 2018

This Biotech is the First to Work on Antivirals for Farm Livestock

…rapidly, gaining resistance to the drug. According to Erwin Blomsma, CEO and co-founder, ViroVet is the only company developing antiviral drugs to combat viral disease in livestock. “We are developing…

October 12, 2018 - 3 minutesmins - By Jonathan Smith

News and Trends 6 Nov 2018

Potential HIV Treatment Shows Early Stage Promise

…reduces blood viral RNA levels, as approved antiretroviral drugs do. However, the company said that the trial also reaffirmed preclinical trials showing the effectiveness of the drug in killing infected…

November 6, 2018 - 3 minutesmins - By Jonathan Smith

News and Trends 31 Aug 2022

United BioPharma gets FDA approval for phase 2 HIV drug trial

…to CD4+ T cells with approximately 50-100-fold higher affinity than HIV-gp120. UB-421 has been shown to inhibit viral entry with viral load reduction potency in phase 1 and phase 2a…

August 31, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 12 Feb 2016

Biotech of the week: Nordic Nanovector & its ARC technology

…biotech of the week, Nordic Nanovector. City: Oslo, Norway Founded: 2009 Employees: +/- 30 (as off 11/15) Financial Data: €156M Market Cap (on 23/11/2015) CEO: CEO, Luigi Costa Missions: Betalutin,…

February 12, 2016 - 1 minutemin - By Philip Hemme

conveyor belt of medical vials for scale up production

News and Trends 7 Oct 2022

Mission Bio launches first commercial high-throughput cell therapy assay for measuring vector copy number

Mission Bio has announced the availability of the Tapestri VCN Assay, the first high-throughput commercial single-cell assay to simultaneously quantify vector copy number (VCN) and transduction at the level of…

October 7, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 22 Jan 2025

Curing ALS? Sixteen companies developing new treatments in 2025

…as frontotemporal dementia and certain forms of Alzheimer’s disease. VectorY Therapeutics Technology: Vectorized antibody therapy Candidate: VTx-002 Recent News: Initiated a biomarker study in collaboration with UMC Utrecht to identify…

January 22, 2025 - 18 minutesmins - By Jules Adam

News and Trends 16 Sep 2024

Vironexis’ AAV vector approach: The next frontier in cancer immunology?

…(FDA). But unlike other immuno-oncology companies, Vironexis’s approach comes with a twist: it uses adeno-associated viruses (AAV) vectors to deliver gene therapy against cancer. Its lead candidate, VNX-101 is set…

September 16, 2024 - 6 minutesmins - By Jules Adam

small respiratory syncytial virus alzheimers disease sweden 1

News and Trends 28 May 2019

Viral Vaccines Could Be Weapons Against Alzheimer’s Disease

…of harmful amyloid fibrils that play a part in Alzheimer’s disease. In spite of the problematic history of Alzheimer’s disease treatments, Ezzat is confident that viral vaccines can provide a…

May 28, 2019 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

Six biotech stocks trading below cash right now

Transgene shares jump 50% in 2 days After Announcing Phase III Trial for Liver Cancer

Beyond Biotech podcast 33: Astellas Pharma, Innovation Agency Lithuania, 4basebio

Nine biotechs thriving in Seattle in 2025

This Biotech is the First to Work on Antivirals for Farm Livestock

Potential HIV Treatment Shows Early Stage Promise

United BioPharma gets FDA approval for phase 2 HIV drug trial

Biotech of the week: Nordic Nanovector & its ARC technology

Mission Bio launches first commercial high-throughput cell therapy assay for measuring vector copy number

Curing ALS? Sixteen companies developing new treatments in 2025

Vironexis’ AAV vector approach: The next frontier in cancer immunology?

Viral Vaccines Could Be Weapons Against Alzheimer’s Disease

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!